Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Receivables - Other (2010 - 2014)

Xtant Medical Holdings (XTNT) reported Receivables - Other of $33468.0 for Q4 2014, up 1.5% year-over-year from $32974.0 in Q4 2013, and little changed on a QoQ basis from $33468.0 in Q2 2014.

Xtant Medical Holdings (XTNT) has 4 years of Receivables - Other data on file, last reported at $33468.0 in Q4 2014.

  • Quarterly Receivables - Other rose 1.5% year-over-year to $33468.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $33468.0 (up 1.5% YoY) and the FY2014 annual result came in at $33468.0, up 1.5% from the prior year.
  • Receivables - Other held at $33468.0 in Q4 2014 per XTNT's latest filing, from $33468.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $675098.0 in Q3 2011 and bottomed at $32974.0 in Q4 2013.
  • The 4-year median for Receivables - Other is $33468.0 (2014), against an average of $298240.4.
  • Peak annual rise in Receivables - Other reached 1.5% in 2014, while the deepest fall reached 1.5% in 2014.
  • Tracing XTNT's Receivables - Other over 4 years: stood at $613034.0 in 2010, then advanced by 10.12% to $675098.0 in 2011, then sank by 95.12% to $32974.0 in 2013, then grew by 1.5% to $33468.0 in 2014.
  • Per Business Quant, the three latest XTNT Receivables - Other figures stand at $33468.0 (Q4 2014), $33468.0 (Q2 2014), and $33468.0 (Q1 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 33,468.00
Dec 31, 2014 33,468.00
Jun 30, 2014 33,468.00
Jun 30, 2014 33,468.00
Mar 31, 2014 33,468.00
Mar 31, 2014 33,468.00
Dec 31, 2013 32,974.00
Dec 31, 2013 32,974.00
Sep 30, 2011 675,098.00
Sep 30, 2011 675,098.00
Jun 30, 2011 666,173.00
Jun 30, 2011 666,173.00
Dec 31, 2010 613,034.00
Dec 31, 2010 613,034.00